Edition:
United States

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

130.63USD
21 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$130.63
Open
$126.01
Day's High
$130.81
Day's Low
$126.01
Volume
98,741
Avg. Vol
98,618
52-wk High
$220.09
52-wk Low
$105.19

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Oyler

50 2010 Executive Chairman of the Board, Chief Executive Officer

Xiaobin Wu

57 2018 General Manager, China and President

Howard Liang

55 2015 Chief Financial Officer and Chief Strategy Officer

Eric Hedrick

50 2019 Interim Chief Medical Officer, Immuno-Oncology

Jane Huang

45 2016 Chief Medical Officer, Hematology